James M. Daly
CIK: 0001560782
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (21 total)
- Oct 16, 2026CYTK
CYTOKINETICS INC
Award(A)Direct195 shares at avg. $63.92$12K - Oct 1, 2026HALO
HALOZYME THERAPEUTICS, INC.
Award(A)Direct1.2K shares- - Jul 15, 2026CYTK
CYTOKINETICS INC
Award(A)Direct151 shares at avg. $82.62$12K - Jun 17, 2026MDGL
MADRIGAL PHARMACEUTICALS, INC.
Award(A)Direct454 shares- - May 29, 2026ACAD
ACADIA PHARMACEUTICALS INC
Exercise(M)Direct8.1K shares- - May 29, 2026ACAD
ACADIA PHARMACEUTICALS INC
Award(A)DirectRestricted Stock Units
9.3K shares- - May 29, 2026ACAD
ACADIA PHARMACEUTICALS INC
Award(A)DirectDirector Stock Options (Right to Buy)
16K shares- - May 27, 2026CYTK
CYTOKINETICS INC
Award(A)Direct2.9K shares- - Apr 15, 2026CYTK
CYTOKINETICS INC
Award(A)Direct191 shares at avg. $65.37$12K - Jan 15, 2026CYTK
CYTOKINETICS INC
Award(A)Direct197 shares at avg. $63.44$12K - Nov 10, 2025ACAD
ACADIA PHARMACEUTICALS INC
Sale(S)Direct30K shares at avg. $22.37$671K - Aug 19, 2025CYTK
CYTOKINETICS INC
Award(A)DirectNon-Qualified Stock Option (Right to Buy)
27.5K shares- - Jun 20, 2025MDGL
MADRIGAL PHARMACEUTICALS, INC.
Award(A)Direct715 shares- - May 29, 2025ACAD
ACADIA PHARMACEUTICALS INC
Exercise(M)Direct9.4K shares- - May 29, 2025ACAD
ACADIA PHARMACEUTICALS INC
Award(A)DirectDirector Stock Options (Right to Buy)
13.8K shares- - May 29, 2025ACAD
ACADIA PHARMACEUTICALS INC
Award(A)DirectRestricted Stock Units
8.1K shares- - Feb 27, 2025MDGL
MADRIGAL PHARMACEUTICALS, INC.
Sale(S)Direct398 shares at avg. $346.90$138K - Feb 27, 2025MDGL
MADRIGAL PHARMACEUTICALS, INC.
Exercise(M)Direct6K shares at avg. $111.06$666K - Feb 27, 2025MDGL
MADRIGAL PHARMACEUTICALS, INC.
Exercise(M)Direct9.5K shares at avg. $65.06$616K - Feb 27, 2025MDGL
MADRIGAL PHARMACEUTICALS, INC.
Sale(S)Direct14.3K shares at avg. $347.39$5.0M - Feb 27, 2025MDGL
MADRIGAL PHARMACEUTICALS, INC.
Sale(S)Direct770 shares at avg. $348.94$269K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Oct 16, 2026 |  CYTK CYTOKINETICS INC | Award(A) | 195 | $63.92 | $12,464 | Direct |
| Oct 1, 2026 |  HALO HALOZYME THERAPEUTICS, INC. | Award(A) | 1,169 | - | $0 | Direct |
| Jul 15, 2026 | CYTK CYTOKINETICS INC | Award(A) | 151 | $82.62 | $12,476 | Direct |
| Jun 17, 2026 |  MDGL MADRIGAL PHARMACEUTICALS, INC. | Award(A) | 454 | - | $0 | Direct |
| May 29, 2026 |  ACAD ACADIA PHARMACEUTICALS INC | Exercise(M) | 8,107 | - | $0 | Direct |
| May 29, 2026 | ACAD ACADIA PHARMACEUTICALS INC | Award(A) Restricted Stock Units | 9,311 | - | - | Direct |
| May 29, 2026 | ACAD ACADIA PHARMACEUTICALS INC | Award(A) Director Stock Options (Right to Buy) | 16,004 | - | - | Direct |
| May 27, 2026 | CYTK CYTOKINETICS INC | Award(A) | 2,851 | - | $0 | Direct |
| Apr 15, 2026 | CYTK CYTOKINETICS INC | Award(A) | 191 | $65.37 | $12,486 | Direct |
| Jan 15, 2026 | CYTK CYTOKINETICS INC | Award(A) | 197 | $63.44 | $12,498 | Direct |
| Nov 10, 2025 | ACAD ACADIA PHARMACEUTICALS INC | Sale(S) | 30,000 | $22.37 | $670,983 | Direct |
| Aug 19, 2025 | CYTK CYTOKINETICS INC | Award(A) Non-Qualified Stock Option (Right to Buy) | 27,450 | - | - | Direct |
| Jun 20, 2025 | MDGL MADRIGAL PHARMACEUTICALS, INC. | Award(A) | 715 | - | - | Direct |
| May 29, 2025 | ACAD ACADIA PHARMACEUTICALS INC | Exercise(M) | 9,387 | - | - | Direct |
| May 29, 2025 | ACAD ACADIA PHARMACEUTICALS INC | Award(A) Director Stock Options (Right to Buy) | 13,793 | - | - | Direct |
| May 29, 2025 | ACAD ACADIA PHARMACEUTICALS INC | Award(A) Restricted Stock Units | 8,107 | - | - | Direct |
| Feb 27, 2025 | MDGL MADRIGAL PHARMACEUTICALS, INC. | Sale(S) | 398 | $346.90 | $138,067 | Direct |
| Feb 27, 2025 | MDGL MADRIGAL PHARMACEUTICALS, INC. | Exercise(M) | 6,000 | $111.06 | $666,360 | Direct |
| Feb 27, 2025 | MDGL MADRIGAL PHARMACEUTICALS, INC. | Exercise(M) | 9,470 | $65.06 | $616,118 | Direct |
| Feb 27, 2025 | MDGL MADRIGAL PHARMACEUTICALS, INC. | Sale(S) | 14,302 | $347.39 | $4,968,372 | Direct |
| Feb 27, 2025 | MDGL MADRIGAL PHARMACEUTICALS, INC. | Sale(S) | 770 | $348.94 | $268,686 | Direct |
1-21 of 21 transactions
About Daly James M
Daly James M (SEC CIK 0001560782) files insider reports with the SEC as Director of CYTOKINETICS INC (CYTK), Director of HALOZYME THERAPEUTICS, INC. (HALO) and Director of MADRIGAL PHARMACEUTICALS, INC. (MDGL). Signal8 also holds filings tied to 1 other company.
Signal8 holds 15 ownership filings by Daly James M (2 Form 3, 13 Form 4), filed between Feb 28, 2025 and Oct 20, 2026. Those filings report 21 transactions, from Feb 27, 2025 to Oct 16, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Daly James M's filings is in SAN DIEGO, CA.
Recent filings by Daly James M
- Oct 16, 2026: Grant or award of CYTK shares (Form 4, code A).
- Oct 1, 2026: Grant or award of HALO shares (Form 4, code A).
- Jul 15, 2026: Grant or award of CYTK shares (Form 4, code A).
- Jun 17, 2026: Grant or award of MDGL shares (Form 4, code A).
- May 29, 2026: Option exercise of ACAD shares (Form 4, code M).
Other insiders filing for CYTOKINETICS INC (CYTK)
- Blum Robert I, President & CEO
- Wysenski Nancy, Director
- Kaye Edward M. MD, Director
- Harrington Robert Arthur, Director
- WIERENGA WENDELL, Director
- HENDERSON JOHN T, Director